NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 45 min 56 sec ago

NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)

Fri, 2024-01-12 01:11
Funding Opportunity RFA-HG-24-013 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) encourages applications for renewal of the NHGRI Technology Development Coordinating Center (TDCC). The TDCC will continue to provide an infrastructure for enhancing and advancing efforts supported by NHGRIs Genome Technology Program. The Centers activities will include facilitating opportunities for new research collaborations to advance technology development and dissemination. The TDCC will also develop outreach strategies and resources to engage the broader biomedical research community and provide an Opportunity Funds Program to support innovative small-scale work.

2024 NIH Grants Policy Updates Join this Virtual Event on Wednesday, January 31 Register Today!

Wed, 2024-01-10 02:14
Notice NOT-OD-24-054 from the NIH Guide for Grants and Contracts

Request for Information (RFI): Increasing the usability of Common Fund data resources by researchers from underrepresented groups

Tue, 2024-01-09 03:03
Notice NOT-RM-24-001 from the NIH Guide for Grants and Contracts

Request for Information: Soliciting Input on a Proposed Traumatic Brain Injury (TBI) Classification System

Tue, 2024-01-09 03:01
Notice NOT-NS-24-027 from the NIH Guide for Grants and Contracts

Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)

Tue, 2024-01-09 02:45
Funding Opportunity RFA-HG-24-001 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for sites to participate in the Genomic Medicine eConsult Research Network, hereafter referred to as the eConsult Network. The eConsult Network will consist of 2-3 sites working with NHGRI to conduct research on the impact of and methods for implementing regional clinician-to-clinician genomic medicine eConsult services. Specifically, sites will be funded to research how to best design, develop, and implement regional genomic medicine eConsult services; provide outreach to potential users, including those at underserved settings; and assess the impact on key stakeholders while developing successful implementation strategies and resources that can be broadly shared and adopted.

Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)

Tue, 2024-01-09 02:37
Funding Opportunity PAR-24-106 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.

Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)

Tue, 2024-01-09 02:32
Funding Opportunity PAR-24-107 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.

Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace

Mon, 2024-01-08 10:58
Notice NOT-MH-24-115 from the NIH Guide for Grants and Contracts

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

Mon, 2024-01-08 10:55
Funding Opportunity PAR-24-060 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

Pages